Role of Pharmacogenetics in Improving the Safety of Psychiatric Care by Predicting the Potential Risks of Mania in CYP2D6 Poor Metabolizers Diagnosed With Bipolar Disorder
about
Association between CYP2D6 Genotypes and the Risk of Antidepressant Discontinuation, Dosage Modification and the Occurrence of Maternal Depression during Pregnancy.Psychiatry meets pharmacogenetics for the treatment of revolving door patients with psychiatric disorders.Should a routine genotyping of CYP2D6 and CYP2C19 genetic polymorphisms be recommended to predict venlafaxine efficacy in depressed patients treated in psychiatric settings?CYP2D6 genotypes in revolving door patients with bipolar disorders: A case series
P2860
Role of Pharmacogenetics in Improving the Safety of Psychiatric Care by Predicting the Potential Risks of Mania in CYP2D6 Poor Metabolizers Diagnosed With Bipolar Disorder
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Role of Pharmacogenetics in Im ...... iagnosed With Bipolar Disorder
@ast
Role of Pharmacogenetics in Im ...... iagnosed With Bipolar Disorder
@en
type
label
Role of Pharmacogenetics in Im ...... iagnosed With Bipolar Disorder
@ast
Role of Pharmacogenetics in Im ...... iagnosed With Bipolar Disorder
@en
prefLabel
Role of Pharmacogenetics in Im ...... iagnosed With Bipolar Disorder
@ast
Role of Pharmacogenetics in Im ...... iagnosed With Bipolar Disorder
@en
P2093
P2860
P1433
P1476
Role of Pharmacogenetics in Im ...... iagnosed With Bipolar Disorder
@en
P2093
Almudena Sanchez-Martín
Andrea Gaedigk
Belén García-Berrocal
Carolina Lorenzo-Romo
José Manuel González-Buitrago
Santiago Sánchez-Iglesias
Tomás Martín-Pinto
Virginia García-Solaesa
P2860
P356
10.1097/MD.0000000000002473
P407
P577
2016-02-01T00:00:00Z